Does insurance cover tirzepatide? Check coverage in 2026

Tirzepatide is one of the most talked-about prescription medications. Sold under the brand names Mounjaro® (for type 2 diabetes) and Zepbound® (for weight loss and obstructive sleep apnea or OSA), it’s considered one of the most effective options available today for these conditions. When used for weight loss, it can help people lose an average of 20 to 21% of their body weight alongside healthy lifestyle changes. 

While tirzepatide can be a powerful tool for weight loss and other conditions, it’s also known for being pricey. Without insurance, the retail cost for both Zepbound® and Mounjaro® can exceed $1,000 per month. While Mounjaro® might be covered when prescribed for type 2 diabetes and Zepbound for OSA, most people who get the medication for weight loss (off-label or not) won’t get insurance coverage. 

Even though weight loss is an approved use of Zepbound®, many insurance plans don’t cover medications specifically prescribed for weight management, even when they cover the same drug for other conditions like type 2 diabetes.

Why? U.S. insurance rules don’t require plans to cover medications prescribed specifically for weight loss. That policy dates back decades, when weight-loss drugs were viewed as lifestyle treatments rather than therapies for a chronic disease.

As a result, even though newer medications like tirzepatide help people lose weight and treat related health risks, insurers are still allowed to leave them off their coverage lists. Coverage ends up inconsistent, even for the same drug.

Let’s walk through how tirzepatide coverage works across major insurance plans, when it might be covered, and what the medication typically costs with and without insurance.

You’ll also learn the key factors insurers look at during prior authorization and the practical steps you can take to check your own coverage.

Is tirzepatide ever covered by insurance?

Yes, tirzepatide can be covered by insurance, but it typically depends on which version you’re prescribed, why you’re taking it, and what insurance plan you have.

In general, insurers are far more likely to approve tirzepatide when it’s prescribed for type 2 diabetes as Mounjaro® or OSA as Zepbound® rather than for weight loss or off-label. 

Checking your specific plan’s formulary and prior authorization requirements is the best way to know where you stand.

How coverage for tirzepatide differs by plan type

Even though Mounjaro^® and Zepbound^® contain the same active ingredient in the same doses, they’re often treated very differently by insurers because of their approved uses.

Mounjaro^® 

• Private / employer-sponsored plans: Many commercial plans cover Mounjaro^® for diabetes, though prior authorization is common. You may need to show an eligible diagnosis, A1C levels, or that you’ve tried other medications first (step therapy). Coverage is extremely unlikely for weight loss medications.
  
• Medicare (Part D): Mounjaro^® is generally covered under many Part D plans when prescribed for type 2 diabetes. But each plan has its own formulary, drug tiers, and approval requirements, which can affect both access and cost.
  
• Medicaid: Most state Medicaid programs include Mounjaro^® for diabetes treatment on their preferred drug lists. That said, prior authorization and state-specific criteria—like step therapy—are still common.

Read more: Mounjaro® costs in 2026: With and without insurance coverage

Zepbound^® 

• Private/employer-sponsored plans: Coverage is variable. Some plans include Zepbound^® for weight management, but it’s still unlikely. When it is covered, strict requirements usually apply, including BMI criteria, related health conditions, and prior authorization. OSA may be covered, but it will depend on the plan.
• Medicare (Part D): Zepbound^® isn’t covered for weight loss due to long-standing federal rules that exclude weight management medications. Coverage may be possible only if prescribed for OSA. 
• Medicaid: Coverage depends heavily on the state. Some Medicaid programs cover GLP-1 medications for weight management with prior authorization, but many restrict or exclude them. Even in states that allow coverage, requirements and access can change frequently.

Read more: Does insurance cover Zepbound®? Check your coverage in 2026

Overall, tirzepatide is more consistently covered when used for diabetes (Mounjaro^®) than for weight management (Zepbound^®). The exact outcome depends on your plan’s rules, formulary, and approval process, so checking your specific benefits is key.

What determines tirzepatide coverage?

Behind every approval or denial is a checklist. Plans evaluate tirzepatide based on medical rules, drug lists, and federal guidance. Seeing the full picture can help you understand why two people with similar prescriptions may have different outcomes.

Key factors include:

• The FDA label: Plans often anchor their decisions to the official FDA approval. The diagnosis listed by your provider needs to align with that labeling. If it doesn’t, the request may face additional scrutiny.
• Clinical documentation: As we mentioned earlier, reviewers look at what’s written in your chart. That can include:
  • The diagnosis code
  • Your BMI, if prescribed for weight management
  • Lab results, such as blood glucose levels
  • Notes describing your medical history
• Prior authorization requirements: Tirzepatide medication typically falls into a category that requires prior authorization. Prior authorization means your provider submits clinical details explaining why this medication fits your health profile.
• Benefit design exclusions: Some plans exclude weight loss medications entirely. In those cases, coverage isn’t determined by your medical record alone, but by the way the benefits were structured when the policy was created.
• Preferred drug lists: Each plan has a formulary. Mounjaro or Zepbound may not always be the preferred medication. Some plans may cover semaglutide (Ozempic or Wegovy) instead. You can explore how those two medications compare here.
• Medicare policy changes: Federal guidance continues to shape access. CMS established a temporary GLP-1 BRIDGE program providing eligible Medicare beneficiaries access to Wegovy and Zepbound at a $50/month copay through 2027. The voluntary BALANCE Model—originally designed to expand Part D coverage starting in 2027—didn’t move forward in Medicare after insufficient plan participation.

All of these factors work together during the review process, and coverage outcomes can widely vary from one plan to another. Curious if your plan covers Zepbound? Use Noom’s Insurance Checker to find out.

What insurance covers tirzepatide medications?

Coverage for tirzepatide can be confusing. Two people with the same prescription can have completely different experiences depending on their plan, employer, or even their state. 

Some plans list Mounjaro^® as a preferred option for diabetes, and others don’t. 

Most large plans use prior authorization (PA) and broader utilization management (UM) programs, which simply means they review certain medications before agreeing to pay for them. Below is a snapshot of how major providers are handling tirzepatide in 2026

Tirzepatide coverage: Private insurance plans

Private insurance coverage can vary widely depending on the insurer, your specific plan, and whether the medication is prescribed for diabetes, OSA, or weight management. 

In general, Mounjaro^® tends to have more consistent coverage for type 2 diabetes, while Zepbound^® may be covered for OSA. Moujaro will almost never be covered for weight loss, and Zepbound may face restrictions or exclusions unless your plan includes a weight-loss benefit. The chart below gives a snapshot of how major insurers typically handle coverage, along with common requirements like prior authorization, and where rules may differ by state or employer plan.

Insurance Provider	Coverage status	Requirements
Aetna	Mounjaro® is listed as a preferred option for diabetes.  Zepbound® may be excluded in some plans. May be covered when prescribed for obstructive sleep apnea (OSA).	Mounjaro: PA and quantity limits (QL) are common.  Zepbound: Weight-loss benefit must be included.
Blue Cross Blue Shield (BCBS)	Mounjaro® is often covered for diabetes. Zepbound® coverage is plan-dependent. Coverage may be more likely if prescribed for another FDA-approved indication, such as OSA.	Mounjaro®: Prior authorization is common Zepbound® (if covered): Prior authorization, documentation of BMI, and a qualifying diagnosis
Cigna	Mounjaro® may be covered under diabetes policy. Zepbound® may be covered for weight loss under the weight loss policy.	Mounjaro®: Prior authorization; may require trial of other therapies Zepbound®: Prior authorization and clinical documentation. Some Cigna plans require documentation of comorbidities (such as hypertension or high cholesterol) or step therapy before approving coverage. Separate PA rules for each use.
UnitedHealthcare (UHC/OptumRx)	Mounjaro® is typically covered for diabetes. Zepbound® is not universally covered. Weight-loss meds are often excluded unless special criteria are met. May be covered for OSA.	Mounjaro®: Prior authorization; documentation of medical necessity Zepbound®: Prior authorization and documentation demonstrating clinical necessity for OSA.
Kaiser Permanente	Mounjaro® is covered for diabetes under many plans; internal review required. Zepbound® isn’t covered for weight loss by many Kaiser Permanente plans. In some cases, employer opt-in is required for coverage to be available. Possible coverage for OSA if certain criteria are met. There are region-specific approval rules.	Mounjaro®: Prior authorization; diagnosis documentation
Humana	Mounjaro® appears on some 2026 formularies. Zepbound®: Humana generally excludes weight-loss GLP-1 medications from standard coverage, including for OSA.	Mounjaro®: Prior authorization; formulary tier placement
Anthem	Mounjaro® is commonly covered for diabetes. Zepbound®: Many Anthem and affiliated BCBS plans exclude weight-loss medications, although some employer-sponsored plans may include coverage depending on benefit design. May be covered when prescribed for OSA, depending on the plan. Coverage varies by state and product line.	Mounjaro®: Prior authorization; may require step therapy Zepbound®: Prior authorization for OSA
Ambetter	Mounjaro® often covered for diabetes. Zepbound® may be covered for OSA. Ambetter plans seldom cover weight-loss medications.	Mounjaro®: Prior authorization Zepbound®: Prior authorization and supporting documentation for OSA.
Oscar Health	Mounjaro®  coverage for diabetes is common on many plans. Zepbound® coverage varies by individual plan and state exchange participation. May be covered for OSA if criteria are met. Approval depends on formulary placement and medical necessity requirements.	Mounjaro®: Prior authorization; formulary review required Zepbound®: Prior authorization based on state rules.
CVS Caremark (PBM)	Mounjaro® coverage depends on the employer or plan sponsor. Zepbound® has been removed from the standard CVS Caremark formulary, including for OSA coverage.	Mounjaro®: Prior authorization; step therapy common
Express Scripts (PBM)	Mounjaro® coverage depends on the employer or plan sponsor. Zepbound® coverage for weight loss or OSA depends on the employer or insurer’s formulary decision. Sponsor-driven coverage decisions.	Mounjaro®: Prior authorization; step therapy often required Zepbound®: Prior authorization

The info above reflects publicly available plan information as of April 2026. Coverage can change, so double-check your plan’s formulary for the latest details.

Tirzepatide coverage: Federal Medicare insurance plans

Federal insurance programs follow a different set of rules than most private plans, which affects how tirzepatide is covered. 

In general, Mounjaro^® is more consistently covered for type 2 diabetes, while weight-loss use is usually excluded under Medicare Part D. 

Zepbound^® and weight-management prescriptions may be covered through TRICARE with approval, prior authorization, and medical necessity documentation. The chart below summarizes typical coverage and requirements for these federal programs.

Insurance Provider	Coverage status	Requirements	Comments
Medicare (Part D)	Mounjaro® may be covered for diabetes. Zepbound®: Coverage is limited and excluded for weight loss. Coverage may apply if prescribed for OSA and meets plan-specific medical criteria.	Mounjaro®: Must meet diabetes indication; formulary inclusion required Zepbound®: Not applicable when prescribed solely for weight loss. Prior authorization for OSA.	Coverage depends on the individual Part D plan.
TRICARE	Mounjaro® is covered for type 2 diabetes when medically necessary. Zepbound®: Coverage for weight loss or OSA may exist under certain TRICARE plans.	Mounjaro®: PA/step therapy and medical necessity documentation required. Zepbound®: PA/step therapy and medical necessity documentation required.	Centralized Military Health System formulary.

Tirzepatide coverage: State Medicaid insurance plans

Medicaid coverage for tirzepatide varies widely because each state manages its own program and sets its own rules. 

While many state Medicaid plans cover Mounjaro^® for type 2 diabetes, coverage for Zepbound^® for weight-management use can differ, often requiring prior authorization or meeting specific medical criteria. The chart below provides an overview of how Medicaid programs typically handle tirzepatide coverage.

Insurance Provider	Coverage Status (Typical)	Requirements	Comments	State Variation
Medicaid	Mounjaro® is commonly covered for diabetes in all states.  Zepbound®: Weight loss coverage varies by state. As of January 2026, only 13 states explicitly cover Zepbound® for weight loss treatment. May be covered for OSA.	Mounjaro®: State-specific PA rules. Zepbound®: State-specific PA and BMI criteria are commonly required. Rules may differ for OSA	Access may shift under the BALANCE Model.	Yes
Molina Healthcare	Mounjaro® is commonly covered for diabetes. Zepbound® coverage for weight loss or OSA depends largely on the state Medicaid program and the specific plan type. Access may be restricted or subject to strict clinical criteria.	Mounjaro®: Prior authorization; Medicaid rules apply where applicable Zepbound®: Prior authorization; Medicaid rules apply where applicable for weight loss and OSA	Rules tied to state Medicaid contracts.	Yes

State-by-state coverage for tirzepatide medications

Where you live can shape what you pay at the pharmacy counter. That’s especially true with Medicaid, since each state runs its own program and sets its own drug rules. Over the past year, several states updated how they handle tirzepatide, particularly for weight management.

Here’s a clearer look at what changed:

State	What’s different here?
California	January 2026 update removed Zepbound® for chronic weight management. Sleep apnea requests may still be reviewed. Mounjaro® stays limited to diabetes treatment.
Pennsylvania	As of January 2026, weight-loss-only use for Zepbound® is no longer covered. Coverage for OSA may exist if certain criteria are met and prior authorization is provided. Mounjaro® for diabetes requires prior authorization.
Michigan	Zepbound® approval is now limited to very high BMI cases for weight loss and OSA. Must show other treatments were tried first. Renewal requires ongoing documentation. Mounjaro® is still covered for diabetes.
North Carolina	Coverage briefly stopped in October 2025, then restarted in December 2025 with stricter rules. Zepbound® is non-preferred, but coveage will continue for OSA. Mounjaro® is still covered for diabetes with prior authorization and medical necessity documentation.
South Carolina	Requests for Zepbound®, for both OSA and weight loss, are denied. Covers Mounjaro® for diabetes with step therapy.
New Hampshire	January 2026 change ended coverage for Zepbound® for weight-loss-only use. Sleep apnea pathway remains with documented diet and PAP therapy steps. Coverage still common for Mounjaro® for diabetes.
Kentucky	Zepbound® approval centers on sleep apnea. Requires sleep study proof and BMI documentation. It is generally not covered for weight loss. Mounjaro® is still covered for diabetes with prior authorization.

Coverage information may vary and change frequently. Always confirm with your state Medicaid office or insurance provider.

How to check if your insurance covers tirzepatide

Getting an answer about insurance coverage for tirzepatide usually takes a little digging. Most plans publish their coverage rules online, but the information is often spread across formularies, benefit summaries, and prior authorization documents. Taking a few minutes to review those details can help you understand what to expect before a prescription is sent in. Or you can use Noom’s Insurance Checker, and we’ll do the work for you in minutes.

Here’s a simple checklist you can follow:

• Call the member services number on your insurance card
  Ask if Zepbound^® or Mounjaro^® is covered under your pharmacy benefit and for which indication. Request written documentation or a link to your plan’s formulary and coverage policy. You can also review your insurer’s online formulary portal. For example, Medicare Part D plans publish formularies publicly each year.

• Ask about prior authorization (PA)
  When GLP-1 medications are covered, most plans require prior authorization, meaning your provider must provide documentation proving medical necessity. Find out what clinical information is required—such as BMI, diagnosis codes, or treatment history.
• Check for step therapy requirements
  Insurers often require step therapy, which means other treatments must be tried first before approving Zepbound^® or Mounjaro^®. Determine if your insurance plan requires step therapy and, if so, which medications must be tried first.
• Confirm BMI and medical criteria
  Coverage for weight loss typically requires documentation of:

• BMI ≥30, or
• BMI ≥27 with a weight-related condition, like high cholesterol or high blood pressure.

Exact thresholds and documentation rules vary by plan and by state Medicaid program.

• Review Medicare or Medicaid rules (If applicable)

• Traditional Medicare Part D doesn’t currently cover medications prescribed solely for weight loss. They might, if used for another FDA-approved indication.
• Medicaid coverage varies by state.
• Use official coverage tools
  Eli Lilly offers a manufacturer coverage resource to help people identify possible coverage options.
• Get everything in writing
  If coverage is approved, denied, or requires additional documentation, request written confirmation. This can help if you need to file an appeal.

Sometimes coverage rules influence which medication makes the most sense. For example, a plan may list semaglutide as preferred instead of tirzepatide. A side-by-side breakdown of tirzepatide and semaglutide is available here.

Cost of tirzepatide medications with and without insurance

The price of tirzepatide medications can differ significantly based on whether you have insurance and the type of plan you’re enrolled in. Even with coverage, most plans won’t pay the entire cost, which makes manufacturer savings programs a key way to lower out-of-pocket expenses. For people without insurance, Zepbound^® offers direct-pay options, with costs varying depending on dose and formulation.

Zepbound: Commercial insurance coverage

When Zepbound^® is covered by a commercial insurance plan, most people end up paying between $25 and $150 per month. The exact out-of-pocket amount depends on your plan’s structure, formulary tier, and whether you use the Lilly Savings Card.

For plans that include coverage for weight-loss medications or obstructive sleep apnea (OSA), Zepbound^® is usually assigned to a formulary tier that requires either a copay (flat fee) or coinsurance (percentage of the drug cost). Lower-tier placements generally mean smaller monthly payments, while higher tiers can result in higher out-of-pocket costs.

How the Zepbound^® Savings Card works:

• Available to eligible commercial insurance holders.
• Can lower copays to as little as $25 per month, depending on plan coverage and eligibility.
• Maximum savings limits:
  • $100 per 1-month prescription
  • $200 per 2-month prescription
  • $300 per 3-month prescription
• Annual savings cap: $1,300 per calendar year.
• Usable for up to 13 prescription fills per year.

Even if your commercial plan doesn’t fully cover Zepbound^®, the savings card may still offer a reduced price, although it will likely be higher than $25.

The Zepbound^® Savings Card can’t be used with Medicare, Medicaid, TRICARE, or other government-funded insurance programs. 

Mounjaro^®: Commercial insurance coverage

Coverage for Mounjaro^® typically applies to type 2 diabetes. Out-of-pocket costs with insurance generally range from $30 to $160 per month, though the final amount depends on your plan’s formulary, cost-sharing structure, and whether you use Eli Lilly’s savings card (for commercially insured people).

For Mounjaro^®, private insurance copays also vary by plan, and coverage is usually tied to type 2 diabetes indications. Eli Lilly offers a savings card for commercially insured people that can significantly reduce out-of-pocket costs.

How the Mounjaro^® savings card works:

• Available to eligible commercially insured individuals.
• Can reduce monthly out-of-pocket costs to as little as $25 to $30, depending on your plan and eligibility.
• Maximum savings of up to:
  • $150 per 1-month prescription
  • $300 per 2-month prescription
  • $450 per 3-month prescription 
  • Separate maximum annual savings of up to $1,950 per calendar year
• If your insurance plan does not cover Mounjaro^®, the program may still provide a discounted cash price, though it will be higher than the fully covered rate.
• To maximize savings, verify eligibility and coordinate with your pharmacy and insurance provider before filling your prescription.

The Mounjaro® Savings Card isn’t available for Medicare, Medicaid, or TRICARE beneficiaries. People covered under these programs must rely on their plan’s formulary coverage and standard cost-sharing rules. Savings cards and manufacturer programs for Mounjaro^® are strictly limited to commercially insured individuals, in compliance with federal regulations.

Tirzepatide cost without insurance

When you’re paying for tirzepatide without insurance, pricing can vary quite a bit depending on which version you’re prescribed and how you choose to fill it.

Zepbound^® and Mounjaro^® contain the same active ingredient, but they’re marketed differently and have different pricing programs—especially for people paying out of pocket.

For Zepbound^®, Eli Lilly offers a structured self-pay option through LillyDirect, which can significantly lower monthly costs compared to retail pharmacy pricing. Mounjaro^®, on the other hand, doesn’t have the same standardized self-pay program, so pricing tends to depend more on pharmacy discounts and location.

Across both medications, your final cost will depend on factors like dose, titration schedule, pharmacy pricing, and whether you use manufacturer programs or discount tools.

Let’s take a closer look at how the costs compare when paying out of pocket:

Medication	Retail price (est.)	Self-pay pricing (2026)	Key requirements
Zepbound®	$1,086/month (single-dose pens)	$299: 2.5 mg $399: 5 mg $449: 7.5 mg–15 mg Applies to both single-dose vials and new multi-dose KwikPen® formats with LillyDirect.	Must have a valid prescription, pay cash, and use the LillyDirect platform
Mounjaro®	$1,112/month	Varies with pharmacy discounts (no standardized program)	Must have a valid prescription; pricing depends on the pharmacy and discount tools

For a closer look at how tirzepatide costs break down across different payment scenarios, read our complete cost guides here:

• Zepbound^® cost without insurance: What to expect in 2026
• Mounjaro^® cost without insurance: What to expect in 2026

Frequently asked questions about insurance coverage for tirzepatide medications

People often have questions about navigating insurance for tirzepatide; here are clear answers to help you understand your options and next steps.

Why is tirzepatide not always covered by insurance?

Coverage decisions usually come down to rules written into your specific plan. Some plans only approve tirzepatide when it is approved for type 2 diabetes for Mounjaro^® or OSA for Zepbound^®. Many plans exclude weight-management medications entirely.

How can I get insurance to cover tirzepatide?

The best way to improve your chances is to ensure your medical record clearly supports the request. That often includes a documented diagnosis, your BMI if it’s prescribed for weight management, and recent lab work when relevant. Your provider may also need to submit prior authorization paperwork explaining why tirzepatide fits your health needs. Taking time to confirm those details before the prescription is sent can help prevent delays.

How much is tirzepatide with insurance coverage?

With commercial coverage, many people pay somewhere between $25 and $150 per month, depending on their plan and drug tier. Savings cards may lower that amount further for eligible people. The exact number depends on your deductible status, prior authorization approval, and whether your plan includes weight-management benefits. Looking at your formulary and drug tier can give you a clearer estimate before you get to the pharmacy.

How do I get tirzepatide for $25?

That lower price usually comes from a Zepbound^® or Mounjaro^® savings card combined with commercial coverage. Eligibility rules apply, and the medication must meet your plan’s approval criteria. The savings card works after your plan processes the claim, reducing your portion of the cost. Checking both your plan coverage and savings card eligibility at the same time helps you see if that price is realistic for you.

What is the cheapest way to get tirzepatide?

The lowest structured cash pricing currently available is through LillyDirect for Zepbound^®, where monthly costs range from $299 to $449, depending on dose for both the single-dose vials and newly introduced KwikPens^®. That pricing is significantly lower than the standard retail list price, which sits just over $1,000 per month. Comparing these direct-pay options before filling at a retail pharmacy can make a noticeable difference.

How much weight can you lose on tirzepatide in 3 months?

Clinical trials show that at 3 months, people taking tirzepatide lost an average of about 9% of their body weight. Keep in mind, though, that results can look different for you, since weight changes depend on your dose, how consistently you take the medication, and your lifestyle habits. Your provider can help set realistic expectations based on your starting point and treatment plan.

How much is tirzepatide if my insurance won’t pay for it?

If you’re paying entirely out of pocket, retail pricing for Mounjaro^® is around $1,112 per month. Pharmacy discount programs may lower Mounjaro^® slightly, sometimes to around $995, though pricing varies by location. 

The retail price for Zepbound^® is around $1,087 per month. Again, through LillyDirect, Zepbound^® single-dose vials and KwikPens^® can range from $299 to $449 per month, depending on dose. 

How long will I need to take tirzepatide?

Tirzepatide is meant to be an ongoing treatment, with most people staying on treatment for at least six months. Many people stay on it as long as it continues to work well for them and feels manageable, especially for chronic conditions like type 2 diabetes or long-term weight management.

Studies on GLP-1 medications, including tirzepatide, show that stopping treatment can lead to weight regain over time. This is why decisions about how long to continue are best made with your provider, so you can create a plan that supports your long-term health goals.

The bottom line: Tirzepatide may be covered based on the medication and condition, but coverage for weight loss is still unlikely

Insurance coverage for tirzepatide often hinges on the details: your diagnosis, documented BMI, prior authorization requirements, and whether your plan even includes weight-management benefits. Some plans approve Mounjaro^® for diabetes more easily than Zepbound^® for chronic weight management. Others require step therapy or additional documentation before moving forward. That’s why reviewing your formulary and asking the right questions upfront can save time and frustration.

For those paying out of pocket, newer pricing programs have changed the landscape. Zepbound^® now offers dose-based cash pricing through LillyDirect, while Mounjaro^® pricing remains closer to standard retail unless discounts apply. Comparing options carefully can make a meaningful difference in your monthly budget.

If you’re considering medication support for weight loss, check your eligibility for Noom Med. Qualified members are connected with licensed clinicians who can prescribe GLP-1 treatments when appropriate and guide you through a plan built around your individual health needs. Along the way, you’ll get practical, behavior-based coaching to support lasting change.